Intuitive Surgical, Inc. (NASDAQ:ISRG) is Sandhill Capital Partners LLC’s 4th Largest Position

Sandhill Capital Partners LLC decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 129,733 shares of the medical equipment provider’s stock after selling 9,440 shares during the quarter. Intuitive Surgical comprises 5.3% of Sandhill Capital Partners LLC’s holdings, making the stock its 4th largest position. Sandhill Capital Partners LLC’s holdings in Intuitive Surgical were worth $67,716,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $25,000. Hurley Capital LLC purchased a new position in Intuitive Surgical in the fourth quarter worth approximately $28,000. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical in the fourth quarter valued at $28,000. Finally, Summit Securities Group LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Royal Bank of Canada raised their price objective on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Erste Group Bank downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Jefferies Financial Group increased their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Leerink Partners boosted their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Finally, Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $463.62 on Tuesday. The firm’s fifty day moving average price is $542.98 and its 200 day moving average price is $532.81. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a market capitalization of $165.13 billion, a price-to-earnings ratio of 72.33, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Insider Activity

In other news, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.